Investing.com - Financial Markets Worldwide

Biocore Co Ltd (216400)

KONEX
Currency in KRW
3,595
+30(+0.84%)
Closed·
216400 Scorecard
Full Analysis
Suffers from weak gross profit margins
216400 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
3,2003,600
52 wk Range
2,6557,790
Key Statistics
Edit
Bid/Ask
3,300.00 / 3,595.00
Prev. Close
3,595
Open
3,400
Day's Range
3,200-3,600
52 wk Range
2,655-7,790
Volume
101
Average Volume (3m)
4.12K
1-Year Change
-51.22%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
216400 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Valuation implies a poor free cash flow yield
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Biocore Co Ltd Company Profile

Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency testing for food and drug safety, impurity testing, testing for licensed pharmaceutical products, and pharmaceutical stability testing. The company also provides disease susceptibility and anticancer drug susceptibility test; personalized genetic testing services, chromosomal microarray analysis, newborn screening, diagnostic exome sequencing, and non-invasive prenatal testing; and sequencing, microarray analysis, Real-Time PCR analysis services. In addition, it offers Real Time PCR Kits; ApoE genotype analysis products; and HLA-B*27 and HLA-B*51 genetic analysis products. Further, the company provides cold-chain and sample transport packaging, data logger device, as well as logistics services. The company was formerly known as Biocore Co., Ltd. and changed its name to Invites Biocore Co., Ltd. in March 2021. Invites Biocore Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.

Industry
Biotechnology & Medical Research
Sector
Healthcare
0
Market
South Korea

Compare 216400 to Peers and Sector

Metrics to compare
216400
Peers
Sector
Relationship
P/E Ratio
0.0x−5.8x−0.5x
PEG Ratio
0.000.030.00
Price/Book
0.0x1.4x2.6x
Price / LTM Sales
0.0x3.3x3.2x
Upside (Analyst Target)
0.0%23.1%38.8%
Fair Value Upside
Unlock2.3%5.4%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

216400 Income Statement

FAQ

What Stock Exchange Does Biocore Trade On?

Biocore is listed and trades on the Korea New Exchange stock exchange.

What Is the Stock Symbol for Biocore?

The stock symbol for Biocore is "216400."

What Is the Biocore Market Cap?

As of today, Biocore market cap is 27.72B.

What Is Biocore's Earnings Per Share (TTM)?

The Biocore EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 216400 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Biocore Stock Split?

Biocore has split 0 times.

How Many Employees Does Biocore Have?

Biocore has 0 employees.

What is the current trading status of Biocore (216400)?

As of 31 Aug 2025, Biocore (216400) is trading at a price of 3,595, with a previous close of 3,595.00. The stock has fluctuated within a day range of 3,200 to 3,600, while its 52-week range spans from 2,655 to 7,790.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.